Brenda Beaty
Concepts (518)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 56 | 2022 | 1205 | 3.000 |
Why?
| Attitude of Health Personnel | 34 | 2021 | 976 | 1.940 |
Why?
| Practice Patterns, Physicians' | 36 | 2021 | 1178 | 1.930 |
Why?
| Physicians, Primary Care | 14 | 2021 | 222 | 1.690 |
Why?
| Influenza Vaccines | 24 | 2021 | 496 | 1.480 |
Why?
| Immunization | 20 | 2021 | 400 | 1.480 |
Why?
| Reminder Systems | 13 | 2021 | 161 | 1.270 |
Why?
| Health Knowledge, Attitudes, Practice | 24 | 2021 | 1184 | 1.210 |
Why?
| Immunization Programs | 18 | 2020 | 206 | 1.200 |
Why?
| Vaccines | 15 | 2021 | 376 | 1.200 |
Why?
| Papillomavirus Vaccines | 12 | 2021 | 222 | 1.090 |
Why?
| Influenza, Human | 18 | 2021 | 546 | 1.080 |
Why?
| Pediatrics | 24 | 2021 | 981 | 1.060 |
Why?
| Physicians, Family | 13 | 2021 | 201 | 0.980 |
Why?
| Primary Health Care | 22 | 2021 | 1512 | 0.940 |
Why?
| Pediatricians | 8 | 2022 | 122 | 0.910 |
Why?
| Papillomavirus Infections | 8 | 2021 | 258 | 0.780 |
Why?
| Pneumococcal Vaccines | 8 | 2021 | 132 | 0.710 |
Why?
| Vaccination Refusal | 5 | 2021 | 69 | 0.690 |
Why?
| Stifle | 1 | 2019 | 4 | 0.670 |
Why?
| Patellar Ligament | 1 | 2019 | 22 | 0.660 |
Why?
| Dog Diseases | 1 | 2019 | 41 | 0.640 |
Why?
| Anterior Cruciate Ligament | 1 | 2019 | 79 | 0.630 |
Why?
| Health Care Surveys | 18 | 2021 | 538 | 0.630 |
Why?
| Herpes Zoster Vaccine | 6 | 2022 | 159 | 0.610 |
Why?
| Mumps | 3 | 2023 | 23 | 0.600 |
Why?
| Osteotomy | 1 | 2019 | 152 | 0.590 |
Why?
| Surveys and Questionnaires | 33 | 2022 | 4631 | 0.590 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2019 | 131 | 0.570 |
Why?
| Female | 105 | 2022 | 59617 | 0.530 |
Why?
| Humans | 157 | 2023 | 115049 | 0.520 |
Why?
| Family Practice | 11 | 2017 | 427 | 0.500 |
Why?
| Male | 94 | 2021 | 55735 | 0.490 |
Why?
| United States | 47 | 2021 | 12227 | 0.480 |
Why?
| Physicians | 11 | 2022 | 772 | 0.480 |
Why?
| Parents | 10 | 2021 | 1190 | 0.460 |
Why?
| Herpes Zoster | 4 | 2022 | 333 | 0.450 |
Why?
| Rotavirus Vaccines | 4 | 2021 | 48 | 0.440 |
Why?
| Immunization Schedule | 6 | 2021 | 184 | 0.440 |
Why?
| Middle Aged | 56 | 2021 | 26830 | 0.430 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2019 | 89 | 0.430 |
Why?
| Adult | 59 | 2022 | 30658 | 0.420 |
Why?
| Insurance, Health, Reimbursement | 6 | 2018 | 88 | 0.420 |
Why?
| Rubella | 2 | 2023 | 19 | 0.420 |
Why?
| Measles | 2 | 2023 | 38 | 0.410 |
Why?
| Terminally Ill | 3 | 2007 | 33 | 0.400 |
Why?
| Rotavirus Infections | 4 | 2021 | 50 | 0.390 |
Why?
| Hypertension | 7 | 2016 | 1058 | 0.370 |
Why?
| Colorado | 33 | 2020 | 4089 | 0.370 |
Why?
| Meningococcal Vaccines | 4 | 2018 | 48 | 0.350 |
Why?
| Community Health Services | 4 | 2017 | 211 | 0.340 |
Why?
| Pregnancy Complications, Infectious | 3 | 2020 | 287 | 0.340 |
Why?
| Infant | 36 | 2022 | 7946 | 0.330 |
Why?
| Child | 40 | 2023 | 18407 | 0.330 |
Why?
| Patient Acceptance of Health Care | 7 | 2016 | 679 | 0.320 |
Why?
| Organ Transplantation | 2 | 2023 | 161 | 0.320 |
Why?
| Anesthesia, Obstetrical | 2 | 1998 | 6 | 0.310 |
Why?
| Stress, Psychological | 4 | 2014 | 946 | 0.300 |
Why?
| Gynecology | 3 | 2019 | 163 | 0.290 |
Why?
| Hospitalization | 6 | 2020 | 1755 | 0.290 |
Why?
| Internal Medicine | 5 | 2014 | 211 | 0.280 |
Why?
| Clinical Competence | 3 | 2018 | 899 | 0.280 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2018 | 97 | 0.270 |
Why?
| Liver Transplantation | 3 | 2019 | 774 | 0.270 |
Why?
| Practice Guidelines as Topic | 10 | 2021 | 1398 | 0.260 |
Why?
| Emergency Medical Services | 2 | 2023 | 587 | 0.260 |
Why?
| Aged | 29 | 2021 | 19122 | 0.250 |
Why?
| Adolescent | 28 | 2023 | 17864 | 0.250 |
Why?
| Insurance, Health | 5 | 2016 | 244 | 0.240 |
Why?
| Child, Preschool | 26 | 2023 | 9093 | 0.240 |
Why?
| Urban Population | 4 | 2017 | 401 | 0.240 |
Why?
| Physician-Patient Relations | 3 | 2019 | 463 | 0.240 |
Why?
| Pneumococcal Infections | 3 | 2018 | 91 | 0.230 |
Why?
| Cohort Studies | 19 | 2023 | 4904 | 0.230 |
Why?
| Professional-Family Relations | 2 | 2016 | 132 | 0.230 |
Why?
| Multivariate Analysis | 13 | 2020 | 1435 | 0.230 |
Why?
| Adolescent Health Services | 3 | 2015 | 68 | 0.220 |
Why?
| Delivery of Health Care | 5 | 2012 | 835 | 0.220 |
Why?
| General Practitioners | 2 | 2021 | 23 | 0.220 |
Why?
| Shock, Traumatic | 1 | 2023 | 16 | 0.220 |
Why?
| Registries | 10 | 2022 | 1763 | 0.210 |
Why?
| Child Health Services | 5 | 2007 | 176 | 0.210 |
Why?
| Chickenpox | 1 | 2023 | 93 | 0.210 |
Why?
| Viral Vaccines | 1 | 2023 | 89 | 0.210 |
Why?
| Attitude to Health | 2 | 2017 | 405 | 0.210 |
Why?
| Pain | 3 | 2009 | 709 | 0.210 |
Why?
| Vaccines, Synthetic | 2 | 2022 | 125 | 0.200 |
Why?
| Data Collection | 12 | 2014 | 623 | 0.200 |
Why?
| Text Messaging | 2 | 2022 | 154 | 0.200 |
Why?
| Health Promotion | 5 | 2015 | 686 | 0.200 |
Why?
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.200 |
Why?
| Follow-Up Studies | 8 | 2019 | 4420 | 0.190 |
Why?
| Prisoners | 2 | 2014 | 124 | 0.190 |
Why?
| Insurance Coverage | 5 | 2018 | 201 | 0.190 |
Why?
| Health Services Accessibility | 6 | 2019 | 765 | 0.190 |
Why?
| Sexually Transmitted Diseases | 3 | 2013 | 154 | 0.190 |
Why?
| Alphapapillomavirus | 1 | 2021 | 36 | 0.190 |
Why?
| Hepatitis B Vaccines | 3 | 2010 | 46 | 0.180 |
Why?
| Treatment Refusal | 2 | 2015 | 85 | 0.180 |
Why?
| Breast Feeding | 4 | 2022 | 367 | 0.180 |
Why?
| Refusal to Treat | 1 | 2020 | 17 | 0.180 |
Why?
| Health Care Costs | 2 | 2017 | 381 | 0.180 |
Why?
| Mobile Applications | 1 | 2022 | 140 | 0.180 |
Why?
| Standing Orders | 1 | 2020 | 11 | 0.180 |
Why?
| Retrospective Studies | 18 | 2019 | 12548 | 0.170 |
Why?
| Advisory Committees | 1 | 2021 | 208 | 0.170 |
Why?
| Norovirus | 1 | 2020 | 23 | 0.170 |
Why?
| Cost-Benefit Analysis | 7 | 2019 | 544 | 0.170 |
Why?
| Resuscitation Orders | 1 | 2020 | 45 | 0.170 |
Why?
| Obstetrics | 2 | 2019 | 146 | 0.170 |
Why?
| Antihypertensive Agents | 3 | 2012 | 430 | 0.160 |
Why?
| Policy | 1 | 2020 | 138 | 0.160 |
Why?
| School Health Services | 3 | 2012 | 206 | 0.160 |
Why?
| Wounds and Injuries | 2 | 2022 | 723 | 0.160 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2016 | 99 | 0.160 |
Why?
| Gastroenteritis | 1 | 2020 | 65 | 0.160 |
Why?
| State Health Plans | 3 | 2005 | 32 | 0.160 |
Why?
| Internet | 7 | 2019 | 600 | 0.160 |
Why?
| Patient Participation | 2 | 2012 | 360 | 0.160 |
Why?
| Pneumonia, Aspiration | 1 | 1998 | 15 | 0.160 |
Why?
| Public Health Practice | 2 | 2012 | 61 | 0.160 |
Why?
| Blood Vessels | 2 | 2016 | 180 | 0.160 |
Why?
| Respiratory Syncytial Virus Vaccines | 1 | 2018 | 24 | 0.160 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 139 | 0.160 |
Why?
| Echocardiography, Stress | 1 | 2018 | 20 | 0.160 |
Why?
| Health Services Research | 5 | 2018 | 371 | 0.150 |
Why?
| Myocardial Perfusion Imaging | 1 | 2018 | 36 | 0.150 |
Why?
| Hospital Costs | 1 | 2019 | 103 | 0.150 |
Why?
| Postoperative Period | 1 | 2019 | 292 | 0.150 |
Why?
| Dogs | 1 | 2019 | 340 | 0.150 |
Why?
| Meningococcal Infections | 1 | 2018 | 20 | 0.150 |
Why?
| Chronic Disease | 7 | 2016 | 1591 | 0.150 |
Why?
| Automobile Driver Examination | 1 | 2017 | 10 | 0.150 |
Why?
| Public Health | 4 | 2015 | 435 | 0.150 |
Why?
| Tibia | 1 | 2019 | 168 | 0.150 |
Why?
| Professional Practice | 1 | 2018 | 62 | 0.150 |
Why?
| Pregnant Women | 1 | 2019 | 131 | 0.150 |
Why?
| Prospective Studies | 10 | 2022 | 6232 | 0.150 |
Why?
| Private Practice | 3 | 2012 | 20 | 0.140 |
Why?
| Herpesvirus 3, Human | 2 | 2019 | 380 | 0.140 |
Why?
| Kidney Transplantation | 1 | 2023 | 549 | 0.140 |
Why?
| Guideline Adherence | 5 | 2016 | 492 | 0.140 |
Why?
| Croup | 1 | 2017 | 22 | 0.140 |
Why?
| Hepatitis A | 1 | 2017 | 26 | 0.140 |
Why?
| Cross Infection | 1 | 2019 | 199 | 0.140 |
Why?
| Myocardial Ischemia | 1 | 2018 | 236 | 0.140 |
Why?
| Regression Analysis | 6 | 2020 | 948 | 0.140 |
Why?
| Infant Mortality | 1 | 1997 | 91 | 0.140 |
Why?
| Physician's Role | 2 | 2019 | 199 | 0.140 |
Why?
| Information Systems | 1 | 2016 | 61 | 0.140 |
Why?
| Biomechanical Phenomena | 1 | 2019 | 675 | 0.130 |
Why?
| Mothers | 3 | 2022 | 652 | 0.130 |
Why?
| Heart Arrest | 1 | 2020 | 289 | 0.130 |
Why?
| Survival Rate | 5 | 2020 | 1646 | 0.130 |
Why?
| Vaccination Coverage | 1 | 2016 | 63 | 0.130 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 65 | 0.130 |
Why?
| Program Evaluation | 3 | 2017 | 825 | 0.130 |
Why?
| Age Factors | 7 | 2021 | 2894 | 0.130 |
Why?
| Ultrasonography | 1 | 2019 | 636 | 0.130 |
Why?
| Health Information Systems | 1 | 2015 | 16 | 0.130 |
Why?
| Directive Counseling | 1 | 2016 | 41 | 0.130 |
Why?
| Health Resources | 1 | 2017 | 122 | 0.130 |
Why?
| Risk Assessment | 5 | 2017 | 2976 | 0.130 |
Why?
| Documentation | 2 | 2015 | 169 | 0.130 |
Why?
| Local Government | 1 | 2015 | 29 | 0.130 |
Why?
| Young Adult | 12 | 2020 | 10498 | 0.120 |
Why?
| Risk-Taking | 3 | 2013 | 333 | 0.120 |
Why?
| Computers, Handheld | 1 | 2015 | 24 | 0.120 |
Why?
| Heart Septum | 1 | 2015 | 26 | 0.120 |
Why?
| Quality Assurance, Health Care | 3 | 2007 | 314 | 0.120 |
Why?
| Rural Population | 3 | 2014 | 446 | 0.120 |
Why?
| Cause of Death | 1 | 1997 | 364 | 0.120 |
Why?
| Communicable Diseases | 1 | 2017 | 130 | 0.120 |
Why?
| Ablation Techniques | 1 | 2015 | 29 | 0.120 |
Why?
| Heart Block | 1 | 2015 | 38 | 0.120 |
Why?
| Risk Factors | 13 | 2017 | 8642 | 0.120 |
Why?
| Diagnostic Tests, Routine | 1 | 2015 | 87 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 124 | 0.120 |
Why?
| Streptococcal Vaccines | 1 | 2014 | 6 | 0.120 |
Why?
| Preventive Health Services | 1 | 2016 | 135 | 0.120 |
Why?
| Gastroenterology | 1 | 2016 | 158 | 0.120 |
Why?
| Medically Uninsured | 4 | 2014 | 121 | 0.120 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 122 | 0.110 |
Why?
| SEER Program | 2 | 2012 | 196 | 0.110 |
Why?
| Public-Private Sector Partnerships | 1 | 2014 | 43 | 0.110 |
Why?
| Quality of Life | 4 | 2008 | 2359 | 0.110 |
Why?
| Clinical Decision-Making | 3 | 2021 | 267 | 0.110 |
Why?
| Inpatients | 1 | 2017 | 378 | 0.110 |
Why?
| Pregnancy | 8 | 2020 | 5520 | 0.110 |
Why?
| Disease Outbreaks | 3 | 2022 | 309 | 0.110 |
Why?
| Palliative Care | 3 | 2008 | 639 | 0.110 |
Why?
| Cardiovascular Diseases | 2 | 2017 | 1729 | 0.110 |
Why?
| Suicide, Attempted | 1 | 2016 | 314 | 0.110 |
Why?
| Referral and Consultation | 2 | 2014 | 633 | 0.110 |
Why?
| Neonatal Screening | 1 | 2014 | 152 | 0.110 |
Why?
| Patient Selection | 2 | 2007 | 646 | 0.110 |
Why?
| Health Education | 1 | 2015 | 323 | 0.100 |
Why?
| South Africa | 2 | 2023 | 161 | 0.100 |
Why?
| Disease Management | 2 | 2017 | 563 | 0.100 |
Why?
| Atherosclerosis | 1 | 2016 | 342 | 0.100 |
Why?
| Blood Pressure | 2 | 2016 | 1539 | 0.100 |
Why?
| Streptococcal Infections | 1 | 2014 | 127 | 0.100 |
Why?
| Electronic Mail | 3 | 2018 | 54 | 0.100 |
Why?
| Infant, Newborn | 9 | 2021 | 5040 | 0.100 |
Why?
| Vaccines, Attenuated | 2 | 2023 | 112 | 0.100 |
Why?
| Craniopharyngioma | 1 | 2012 | 65 | 0.100 |
Why?
| Developmental Disabilities | 1 | 2014 | 238 | 0.100 |
Why?
| Hyperlipidemias | 1 | 2012 | 122 | 0.100 |
Why?
| Poverty | 6 | 2017 | 443 | 0.100 |
Why?
| Attitude | 2 | 2021 | 227 | 0.100 |
Why?
| Suicidal Ideation | 1 | 2016 | 397 | 0.100 |
Why?
| Medication Adherence | 3 | 2012 | 537 | 0.090 |
Why?
| Interviews as Topic | 5 | 2014 | 584 | 0.090 |
Why?
| Continuity of Patient Care | 1 | 2013 | 253 | 0.090 |
Why?
| Critical Pathways | 1 | 2012 | 74 | 0.090 |
Why?
| Pituitary Neoplasms | 1 | 2012 | 157 | 0.090 |
Why?
| Vascular Stiffness | 1 | 2015 | 408 | 0.090 |
Why?
| Safety | 1 | 2013 | 297 | 0.090 |
Why?
| Seasons | 4 | 2020 | 448 | 0.090 |
Why?
| Firearms | 1 | 2016 | 294 | 0.090 |
Why?
| Patients | 2 | 2018 | 162 | 0.090 |
Why?
| Acculturation | 1 | 2011 | 50 | 0.090 |
Why?
| Condoms | 2 | 2009 | 113 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 128 | 0.090 |
Why?
| Neoplasms | 3 | 2009 | 2106 | 0.090 |
Why?
| Licensure, Medical | 1 | 2010 | 12 | 0.090 |
Why?
| Ethanol | 1 | 2015 | 548 | 0.090 |
Why?
| Child Abuse | 1 | 2015 | 451 | 0.090 |
Why?
| Drug Recalls | 1 | 2010 | 5 | 0.090 |
Why?
| Albuterol | 1 | 2011 | 103 | 0.090 |
Why?
| Haemophilus Vaccines | 1 | 2010 | 27 | 0.090 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2015 | 1215 | 0.090 |
Why?
| Haemophilus influenzae | 1 | 2010 | 48 | 0.090 |
Why?
| Haemophilus Infections | 1 | 2010 | 28 | 0.090 |
Why?
| Medicare Part D | 1 | 2010 | 26 | 0.090 |
Why?
| Social Class | 2 | 2009 | 205 | 0.090 |
Why?
| Audiovisual Aids | 1 | 2009 | 15 | 0.090 |
Why?
| Evidence-Based Medicine | 3 | 2020 | 676 | 0.090 |
Why?
| Polysaccharides, Bacterial | 1 | 2010 | 66 | 0.090 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.080 |
Why?
| Public Assistance | 1 | 2009 | 18 | 0.080 |
Why?
| Research Design | 1 | 2015 | 930 | 0.080 |
Why?
| Family Nursing | 1 | 2009 | 12 | 0.080 |
Why?
| Practice Management, Medical | 1 | 2009 | 34 | 0.080 |
Why?
| Quality Improvement | 2 | 2014 | 953 | 0.080 |
Why?
| Costs and Cost Analysis | 3 | 2018 | 196 | 0.080 |
Why?
| Patient-Centered Care | 2 | 2013 | 474 | 0.080 |
Why?
| Cross-Sectional Studies | 8 | 2016 | 4411 | 0.080 |
Why?
| Incidence | 5 | 2017 | 2318 | 0.080 |
Why?
| Aged, 80 and over | 5 | 2020 | 6357 | 0.080 |
Why?
| Sexual Behavior | 2 | 2013 | 440 | 0.080 |
Why?
| Computer-Assisted Instruction | 1 | 2009 | 64 | 0.080 |
Why?
| Bronchodilator Agents | 1 | 2011 | 243 | 0.080 |
Why?
| Substance-Related Disorders | 2 | 2014 | 946 | 0.080 |
Why?
| User-Computer Interface | 1 | 2009 | 143 | 0.080 |
Why?
| Pain Management | 2 | 2009 | 289 | 0.080 |
Why?
| Prostatic Neoplasms | 2 | 2006 | 921 | 0.080 |
Why?
| Time Factors | 8 | 2012 | 6141 | 0.080 |
Why?
| Logistic Models | 6 | 2012 | 1839 | 0.080 |
Why?
| Hepatitis B | 1 | 2009 | 51 | 0.080 |
Why?
| Emergency Service, Hospital | 3 | 2016 | 1812 | 0.080 |
Why?
| Patient Access to Records | 2 | 2005 | 20 | 0.080 |
Why?
| Fetus | 2 | 2004 | 702 | 0.080 |
Why?
| Condoms, Female | 1 | 2008 | 6 | 0.080 |
Why?
| Health Services Needs and Demand | 2 | 2007 | 245 | 0.080 |
Why?
| Social Marketing | 1 | 2008 | 13 | 0.080 |
Why?
| Algorithms | 1 | 2015 | 1489 | 0.080 |
Why?
| Treatment Outcome | 7 | 2023 | 9123 | 0.080 |
Why?
| Reproductive Medicine | 1 | 2008 | 15 | 0.080 |
Why?
| Complementary Therapies | 1 | 2009 | 72 | 0.080 |
Why?
| Massage | 1 | 2008 | 42 | 0.080 |
Why?
| Quality of Health Care | 2 | 2005 | 573 | 0.080 |
Why?
| Neuralgia, Postherpetic | 1 | 2008 | 44 | 0.070 |
Why?
| Sentinel Surveillance | 1 | 2008 | 38 | 0.070 |
Why?
| Alcoholism | 1 | 2014 | 716 | 0.070 |
Why?
| Medicaid | 3 | 2021 | 409 | 0.070 |
Why?
| Drug Prescriptions | 1 | 2009 | 239 | 0.070 |
Why?
| Diabetes Mellitus | 2 | 2012 | 906 | 0.070 |
Why?
| HIV Infections | 2 | 2013 | 2470 | 0.070 |
Why?
| Sex Factors | 3 | 2020 | 1721 | 0.070 |
Why?
| Hospice Care | 2 | 2007 | 185 | 0.070 |
Why?
| Proxy | 1 | 2006 | 23 | 0.070 |
Why?
| Employment | 1 | 2008 | 139 | 0.070 |
Why?
| Affect | 1 | 2008 | 246 | 0.070 |
Why?
| Terminal Care | 2 | 2006 | 213 | 0.070 |
Why?
| Social Support | 1 | 2010 | 528 | 0.070 |
Why?
| Kidney Diseases | 1 | 2009 | 350 | 0.070 |
Why?
| Vulnerable Populations | 1 | 2006 | 134 | 0.060 |
Why?
| Information Services | 1 | 2005 | 45 | 0.060 |
Why?
| Health Status Indicators | 1 | 2006 | 154 | 0.060 |
Why?
| Marital Status | 1 | 2005 | 41 | 0.060 |
Why?
| Hypoglycemic Agents | 1 | 2012 | 1006 | 0.060 |
Why?
| Patient Satisfaction | 2 | 2005 | 580 | 0.060 |
Why?
| Survivors | 1 | 2008 | 410 | 0.060 |
Why?
| Direct Service Costs | 1 | 2004 | 10 | 0.060 |
Why?
| Medical Assistance | 1 | 2004 | 13 | 0.060 |
Why?
| Postal Service | 2 | 2018 | 29 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2018 | 498 | 0.060 |
Why?
| Odds Ratio | 3 | 2013 | 957 | 0.060 |
Why?
| Socioeconomic Factors | 4 | 2011 | 1081 | 0.060 |
Why?
| Health Services | 1 | 2005 | 103 | 0.060 |
Why?
| Forms and Records Control | 1 | 2004 | 22 | 0.060 |
Why?
| Vaccines, Combined | 1 | 2023 | 46 | 0.060 |
Why?
| Asthma | 4 | 2011 | 2051 | 0.060 |
Why?
| Social Environment | 1 | 2005 | 284 | 0.060 |
Why?
| Colonoscopy | 1 | 2005 | 204 | 0.050 |
Why?
| Public Health Informatics | 1 | 2003 | 7 | 0.050 |
Why?
| Chickenpox Vaccine | 1 | 2023 | 69 | 0.050 |
Why?
| Hospices | 1 | 2004 | 83 | 0.050 |
Why?
| Ultrasonography, Prenatal | 2 | 2004 | 235 | 0.050 |
Why?
| Comparative Effectiveness Research | 2 | 2015 | 130 | 0.050 |
Why?
| Ambulances | 1 | 2023 | 50 | 0.050 |
Why?
| Health Personnel | 2 | 2019 | 574 | 0.050 |
Why?
| Health Status | 1 | 2008 | 722 | 0.050 |
Why?
| Efficiency, Organizational | 1 | 2004 | 124 | 0.050 |
Why?
| Kidney | 1 | 2009 | 1186 | 0.050 |
Why?
| Vaccines, Conjugate | 2 | 2018 | 60 | 0.050 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2022 | 40 | 0.050 |
Why?
| Transplant Recipients | 1 | 2023 | 143 | 0.050 |
Why?
| Health Surveys | 2 | 2018 | 443 | 0.050 |
Why?
| Risk Reduction Behavior | 2 | 2017 | 201 | 0.050 |
Why?
| Meconium | 1 | 2001 | 7 | 0.050 |
Why?
| Medicare | 2 | 2018 | 666 | 0.050 |
Why?
| Meconium Aspiration Syndrome | 1 | 2001 | 11 | 0.050 |
Why?
| Mumps Vaccine | 1 | 2021 | 13 | 0.050 |
Why?
| Educational Status | 2 | 2017 | 412 | 0.050 |
Why?
| Hospitals, Pediatric | 2 | 2015 | 477 | 0.050 |
Why?
| Nasopharynx | 1 | 2001 | 63 | 0.050 |
Why?
| Length of Stay | 3 | 2018 | 951 | 0.050 |
Why?
| Milk, Human | 1 | 2022 | 128 | 0.050 |
Why?
| Cooperative Behavior | 2 | 2015 | 383 | 0.050 |
Why?
| Health Policy | 1 | 2004 | 334 | 0.050 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 94 | 0.050 |
Why?
| Body Composition | 1 | 2004 | 586 | 0.050 |
Why?
| Vaccines, Inactivated | 1 | 2021 | 68 | 0.050 |
Why?
| Animals | 3 | 2019 | 31868 | 0.050 |
Why?
| Living Donors | 1 | 2023 | 306 | 0.040 |
Why?
| Islets of Langerhans | 2 | 1996 | 729 | 0.040 |
Why?
| Intussusception | 2 | 2013 | 27 | 0.040 |
Why?
| Tetanus Toxoid | 2 | 2012 | 37 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2000 | 105 | 0.040 |
Why?
| Prognosis | 3 | 2017 | 3335 | 0.040 |
Why?
| New York | 1 | 2020 | 107 | 0.040 |
Why?
| Fetal Growth Retardation | 1 | 2004 | 466 | 0.040 |
Why?
| Pandemics | 2 | 2021 | 1322 | 0.040 |
Why?
| Age Distribution | 2 | 2013 | 340 | 0.040 |
Why?
| Colorectal Neoplasms | 1 | 2005 | 617 | 0.040 |
Why?
| Infant Formula | 2 | 2010 | 74 | 0.040 |
Why?
| Blood Flow Velocity | 1 | 2000 | 390 | 0.040 |
Why?
| Outpatient Clinics, Hospital | 2 | 2011 | 79 | 0.040 |
Why?
| Serogroup | 1 | 2018 | 26 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2017 | 1812 | 0.040 |
Why?
| Pharmacists | 1 | 2021 | 236 | 0.040 |
Why?
| Pilot Projects | 2 | 2015 | 1375 | 0.040 |
Why?
| Patient Discharge | 1 | 2004 | 767 | 0.040 |
Why?
| Comorbidity | 2 | 2013 | 1457 | 0.040 |
Why?
| Hospital Charges | 1 | 2018 | 38 | 0.040 |
Why?
| HLA Antigens | 2 | 1996 | 224 | 0.040 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2018 | 60 | 0.040 |
Why?
| Morbidity | 1 | 2019 | 279 | 0.040 |
Why?
| Diphtheria | 1 | 2017 | 20 | 0.040 |
Why?
| Tetanus | 1 | 2017 | 25 | 0.040 |
Why?
| Chest Pain | 1 | 2018 | 81 | 0.040 |
Why?
| Awareness | 1 | 2018 | 92 | 0.040 |
Why?
| Whooping Cough | 1 | 2017 | 49 | 0.040 |
Why?
| Immunization, Secondary | 2 | 2010 | 82 | 0.040 |
Why?
| Population Groups | 1 | 2017 | 57 | 0.040 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2020 | 220 | 0.040 |
Why?
| Healthy Lifestyle | 1 | 2017 | 29 | 0.040 |
Why?
| Demography | 2 | 2008 | 261 | 0.040 |
Why?
| Transplantation Immunology | 1 | 2017 | 30 | 0.040 |
Why?
| Cost of Illness | 1 | 2018 | 254 | 0.030 |
Why?
| Lipoproteins, LDL | 1 | 2017 | 129 | 0.030 |
Why?
| Health Plan Implementation | 1 | 2018 | 132 | 0.030 |
Why?
| Professional Practice Gaps | 1 | 2016 | 10 | 0.030 |
Why?
| Palivizumab | 1 | 2016 | 13 | 0.030 |
Why?
| Altitude | 1 | 2000 | 434 | 0.030 |
Why?
| Milk Proteins | 1 | 1996 | 36 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2017 | 122 | 0.030 |
Why?
| Administration, Oral | 1 | 1998 | 730 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 1996 | 3245 | 0.030 |
Why?
| Liver Failure | 1 | 2016 | 79 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2017 | 387 | 0.030 |
Why?
| Focus Groups | 1 | 2017 | 385 | 0.030 |
Why?
| Milk | 1 | 1996 | 124 | 0.030 |
Why?
| Equipment and Supplies | 1 | 2015 | 38 | 0.030 |
Why?
| Exercise Test | 1 | 2018 | 545 | 0.030 |
Why?
| Contrast Media | 1 | 2018 | 369 | 0.030 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2015 | 48 | 0.030 |
Why?
| Canada | 1 | 2016 | 322 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 208 | 0.030 |
Why?
| Immunocompromised Host | 1 | 2017 | 196 | 0.030 |
Why?
| Triglycerides | 1 | 2017 | 471 | 0.030 |
Why?
| Mass Screening | 2 | 2005 | 1012 | 0.030 |
Why?
| Retreatment | 1 | 2015 | 67 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| Heart Rate | 1 | 2018 | 705 | 0.030 |
Why?
| Ventricular Outflow Obstruction | 1 | 2015 | 38 | 0.030 |
Why?
| Graft Survival | 1 | 2017 | 464 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2021 | 2389 | 0.030 |
Why?
| Unemployment | 1 | 2014 | 39 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 458 | 0.030 |
Why?
| Communication | 1 | 2019 | 744 | 0.030 |
Why?
| Bisexuality | 1 | 2013 | 17 | 0.030 |
Why?
| Decision Support Systems, Clinical | 1 | 2016 | 177 | 0.030 |
Why?
| Consumer Behavior | 1 | 2014 | 66 | 0.030 |
Why?
| Homosexuality, Female | 1 | 2013 | 25 | 0.030 |
Why?
| Graft Rejection | 1 | 2017 | 522 | 0.030 |
Why?
| Unsafe Sex | 1 | 2013 | 58 | 0.030 |
Why?
| Societies, Medical | 1 | 2017 | 678 | 0.030 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 372 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 1715 | 0.030 |
Why?
| Circovirus | 1 | 2013 | 7 | 0.030 |
Why?
| Social Behavior | 1 | 2015 | 267 | 0.030 |
Why?
| Community Mental Health Services | 1 | 2013 | 84 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 1996 | 394 | 0.030 |
Why?
| Housing | 1 | 2014 | 114 | 0.030 |
Why?
| Sex Distribution | 1 | 2013 | 335 | 0.030 |
Why?
| Qualitative Research | 1 | 2017 | 935 | 0.030 |
Why?
| Drug Contamination | 1 | 2013 | 53 | 0.030 |
Why?
| Hospital Mortality | 1 | 1997 | 777 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2014 | 185 | 0.030 |
Why?
| Product Surveillance, Postmarketing | 1 | 2013 | 63 | 0.030 |
Why?
| Homosexuality, Male | 1 | 2013 | 170 | 0.030 |
Why?
| Databases, Factual | 1 | 2017 | 1132 | 0.030 |
Why?
| Patient Compliance | 2 | 2012 | 524 | 0.030 |
Why?
| Autoantibodies | 2 | 1996 | 1354 | 0.020 |
Why?
| Self Report | 1 | 2016 | 698 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2012 | 89 | 0.020 |
Why?
| Double-Blind Method | 1 | 2015 | 1665 | 0.020 |
Why?
| Interpersonal Relations | 1 | 2014 | 339 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2012 | 307 | 0.020 |
Why?
| Autoimmunity | 1 | 1996 | 818 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 79 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2011 | 103 | 0.020 |
Why?
| Fees, Pharmaceutical | 1 | 2010 | 13 | 0.020 |
Why?
| Swine | 1 | 2013 | 704 | 0.020 |
Why?
| Fees, Medical | 1 | 2009 | 9 | 0.020 |
Why?
| Gestational Age | 2 | 2004 | 758 | 0.020 |
Why?
| Multilingualism | 1 | 2009 | 26 | 0.020 |
Why?
| Drug Utilization | 1 | 2011 | 167 | 0.020 |
Why?
| Electronic Health Records | 1 | 2016 | 799 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2012 | 1127 | 0.020 |
Why?
| Caregivers | 2 | 2006 | 712 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
| Telephone | 1 | 2010 | 152 | 0.020 |
Why?
| Community-Based Participatory Research | 1 | 2009 | 130 | 0.020 |
Why?
| Blood Glucose | 1 | 2017 | 1821 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 2799 | 0.020 |
Why?
| Epidemiologic Research Design | 1 | 2008 | 27 | 0.020 |
Why?
| Diabetes Complications | 1 | 2009 | 212 | 0.020 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2009 | 133 | 0.020 |
Why?
| Single-Blind Method | 1 | 2008 | 258 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1857 | 0.020 |
Why?
| Health Care Rationing | 1 | 2007 | 45 | 0.020 |
Why?
| Psychology | 1 | 2008 | 81 | 0.020 |
Why?
| Vascular Diseases | 1 | 2009 | 231 | 0.020 |
Why?
| Office Visits | 1 | 2006 | 79 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2009 | 604 | 0.020 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 1996 | 44 | 0.020 |
Why?
| Biomarkers | 2 | 2012 | 3419 | 0.020 |
Why?
| Glutamate Decarboxylase | 2 | 1996 | 160 | 0.020 |
Why?
| Insulin Antibodies | 2 | 1996 | 102 | 0.020 |
Why?
| Psychosocial Deprivation | 1 | 2005 | 5 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2010 | 682 | 0.020 |
Why?
| Protein Tyrosine Phosphatases | 2 | 1996 | 147 | 0.020 |
Why?
| Health Behavior | 1 | 2011 | 704 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2009 | 1169 | 0.020 |
Why?
| Urban Health | 1 | 2005 | 73 | 0.020 |
Why?
| Rural Health | 1 | 2005 | 67 | 0.020 |
Why?
| Medical Staff, Hospital | 1 | 2005 | 74 | 0.020 |
Why?
| Prostatectomy | 1 | 2005 | 98 | 0.010 |
Why?
| Mass Media | 1 | 2005 | 37 | 0.010 |
Why?
| Karnofsky Performance Status | 1 | 2004 | 36 | 0.010 |
Why?
| Time and Motion Studies | 1 | 2004 | 21 | 0.010 |
Why?
| Biometry | 1 | 2004 | 63 | 0.010 |
Why?
| Brachytherapy | 1 | 2005 | 103 | 0.010 |
Why?
| Perception | 1 | 2007 | 310 | 0.010 |
Why?
| Feeding Behavior | 1 | 2009 | 574 | 0.010 |
Why?
| Probability | 1 | 2005 | 289 | 0.010 |
Why?
| Ohio | 1 | 2004 | 136 | 0.010 |
Why?
| Internship and Residency | 1 | 2013 | 941 | 0.010 |
Why?
| Professional-Patient Relations | 1 | 2005 | 140 | 0.010 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 242 | 0.010 |
Why?
| Body Size | 1 | 2004 | 91 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1392 | 0.010 |
Why?
| Policy Making | 1 | 2004 | 81 | 0.010 |
Why?
| Eligibility Determination | 1 | 2004 | 60 | 0.010 |
Why?
| Patient Care | 1 | 2004 | 103 | 0.010 |
Why?
| Femur | 1 | 2004 | 193 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2011 | 2551 | 0.010 |
Why?
| Recurrence | 1 | 2005 | 941 | 0.010 |
Why?
| Mortality | 1 | 2004 | 287 | 0.010 |
Why?
| Apgar Score | 1 | 2001 | 16 | 0.010 |
Why?
| Bone and Bones | 1 | 2004 | 280 | 0.010 |
Why?
| Perineum | 1 | 2001 | 26 | 0.010 |
Why?
| Suction | 1 | 2001 | 31 | 0.010 |
Why?
| Endpoint Determination | 1 | 2001 | 69 | 0.010 |
Why?
| Delivery, Obstetric | 1 | 2001 | 118 | 0.010 |
Why?
| Umbilical Cord | 1 | 2000 | 80 | 0.010 |
Why?
| Private Sector | 1 | 2000 | 51 | 0.010 |
Why?
| Exercise | 1 | 2009 | 1644 | 0.010 |
Why?
| Patient Readmission | 1 | 2004 | 606 | 0.010 |
Why?
| Arteries | 1 | 2000 | 249 | 0.010 |
Why?
| Birth Weight | 1 | 2000 | 440 | 0.010 |
Why?
| Acute Disease | 1 | 2000 | 915 | 0.010 |
Why?
| Histocompatibility Testing | 1 | 1996 | 116 | 0.010 |
Why?
| Infant Food | 1 | 1996 | 63 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 144 | 0.010 |
Why?
| HLA-DQ Antigens | 1 | 1996 | 177 | 0.010 |
Why?
| Dietary Proteins | 1 | 1996 | 123 | 0.010 |
Why?
| HLA-DR Antigens | 1 | 1996 | 220 | 0.010 |
Why?
| DNA Primers | 1 | 1996 | 514 | 0.010 |
Why?
| Fetal Blood | 1 | 1996 | 270 | 0.010 |
Why?
| Alleles | 1 | 1996 | 792 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1996 | 999 | 0.010 |
Why?
| Survival Analysis | 1 | 1996 | 1211 | 0.010 |
Why?
| Genotype | 1 | 1996 | 1780 | 0.010 |
Why?
|
|
Beaty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|